![Alaxia breaks new ground with lead compound ALX-009 as virucidal agent](https://ala.associates/wp-content/uploads/2020/09/DSC_7770-1080x675.jpg)
![Alaxia breaks new ground with lead compound ALX-009 as virucidal agent](https://ala.associates/wp-content/uploads/2020/09/DSC_7770-1080x675.jpg)
![ANS Biotech appoints Dr. Philippe Genne to board of directors](https://ala.associates/wp-content/uploads/2020/09/LaCourtoisie-853x675.jpg)
ANS Biotech appoints Dr. Philippe Genne to board of directors
![Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc.](https://ala.associates/wp-content/uploads/2021/04/Pascal-NEUVILLE_DOMAIN-Therapeutics_portrait-6-1-895x675.png)
Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc.
![Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology](https://ala.associates/wp-content/uploads/2020/07/Alain-Huriez-1-e1584455743406.jpg)
Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology
![Fab’entech launches COVID-19 immunotherapy program](https://ala.associates/wp-content/uploads/2020/07/cdc-w9KEokhajKw-unsplash-copie-1080x675.jpg)
Fab’entech launches COVID-19 immunotherapy program
![Tollys receives over €1.5 million deep tech financing from Bpifrance](https://ala.associates/wp-content/uploads/2022/02/IMG_3074-512x675.jpg)
Tollys receives over €1.5 million deep tech financing from Bpifrance
![BCI Pharma appoints Didier Malherbe as chairman of board of directors](https://ala.associates/wp-content/uploads/2020/07/DM-A-Essenscia.jpg)
BCI Pharma appoints Didier Malherbe as chairman of board of directors
![Advanced BioDesign and Luxembourg Institute of Health (LIH) join forces to explore new therapeutic strategies for overcoming tumor resistance](https://ala.associates/wp-content/uploads/2020/07/807aa2d3aac146aa8acebafdb317e175WoxnIkKZFgrN5r69-2.png)
Advanced BioDesign and Luxembourg Institute of Health (LIH) join forces to explore new therapeutic strategies for overcoming tumor resistance
![PDC*line Pharma welcomes Dr. Mondher Mahjoubi as chairman of its board of directors](https://ala.associates/wp-content/uploads/2020/06/Mondher-Mahjoubi-1-1-1080x675.jpg)
PDC*line Pharma welcomes Dr. Mondher Mahjoubi as chairman of its board of directors
![Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc.](https://ala.associates/wp-content/uploads/2021/04/Pascal-NEUVILLE_DOMAIN-Therapeutics_portrait-6-1-895x675.png)